Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.

Mauro Malnati(Vita-Salute San Raffaele University), Paolo Lusso(National Institute of Allergy and Infectious Diseases), Adriano Lazzarin(Vita-Salute San Raffaele University), Vanessa Nardese(Vita-Salute San Raffaele University), Margherita Algeri(Vita-Salute San Raffaele University), Giuseppe Tambussi(San Raffaele University of Rome), Simona Polo(Ian's Friends Foundation), Elena Clerici, Lucinda Furci(Vita-Salute San Raffaele University)
PubMed
January 27, 1998
Cited by 25

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
|Immunity|1995|574
CD46 Is a Cellular Receptor for Human Herpesvirus 6
|Cell|1999|525